Etomidate Versus Ketamine for Emergency Endotracheal Intubation: a Prospective Randomized Clinical Trial
EvK
1 other identifier
interventional
801
1 country
1
Brief Summary
Patients who are having problems breathing sometimes require placement of a breathing tube in their mouth and windpipe. The purpose of this breathing tube is to save the patient's life. It is common to give the patient a medication to sedate him or her before the breathing tube is placed. For patients who are gravely ill two medications are commonly used: etomidate or ketamine. Both medications have risks and benefits. Researchers at UT-Southwestern Medical Center and Parkland Memorial Hospital would like to do a study to figure out which one is better for our patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Jun 2016
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 11, 2015
CompletedFirst Posted
Study publicly available on registry
December 31, 2015
CompletedStudy Start
First participant enrolled
June 6, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedResults Posted
Study results publicly available
December 15, 2021
CompletedDecember 15, 2021
November 1, 2021
4.5 years
December 11, 2015
November 15, 2021
November 15, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Survival at Day 7
Survival is defined as the number of participants survived at day 7 following emergency endotracheal intubation
Day 7
Secondary Outcomes (7)
Survival at Day 28
Day 28
Sequential Organ Failure Assessment (SOFA) Scores
Day 1, Day 2, Day 3, Day 4
Duration of Mechanical Ventilation
From time of documented insertion until the time of documented removal, assessed up to 28 days
Duration of Catecholamine Therapy
From time of documented start of therapy until the time of documented end of therapy, assessed up to 28 days
Length of Stay in ICU
Assessed up to 28 days
- +2 more secondary outcomes
Study Arms (2)
Etomidate
EXPERIMENTALPatients randomized to this group will receive etomidate immediately prior to emergency endotracheal intubation.
Ketamine
EXPERIMENTALPatients randomized to this group will receive ketamine immediately prior to emergency endotracheal intubation.
Interventions
Patients randomized to this group will receive etomidate immediately prior to emergency endotracheal intubation.
Patients randomized to this group will receive ketamine immediately prior to emergency endotracheal intubation.
Patients enrolled in the study will be endotracheally intubated. (A breathing tube will be placed into the patient's mouth and trachea). This procedure is being done as part of standard emergency care. Standard endotracheal tubes will be used. Our hospital uses primarily Mallinckrodt (TM) brand endotracheal tubes.
Patients enrolled in the study will be mechanically ventilated, using a standard ventilator used in our hospital. The mechanical ventilator is attached to the patient's endotracheal tube and helps sustain the patient's life. Our hospital uses several brands of mechanical ventilators.
Eligibility Criteria
You may qualify if:
- Adult patient (male or female) requiring emergency endotracheal intubation.
You may not qualify if:
- Children (\<18 years old).
- Women who are known to be pregnant.
- Any patient who has been previously randomized in the EvK Trial.
- Patients who require endotracheal intubation without sedative medication. For example, patients in full cardiac arrest.
- Patients with a known allergy to ketamine or etomidate.
- Any individual wearing a MedAlert bracelet indicating that he/she has formally opted out of the EvK Trial.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Parkland Hospital
Dallas, Texas, 75235, United States
Related Publications (2)
Matchett G, Ryan TJ, Sunna MC, Lee SC, Pepe PE; EvK Clinical Trial Group. Measuring the cost and effect of current community consultation and public disclosure techniques in emergency care research. Resuscitation. 2018 Jul;128:37-42. doi: 10.1016/j.resuscitation.2018.04.033. Epub 2018 Apr 30.
PMID: 29715485RESULTMatchett G, Gasanova I, Riccio CA, Nasir D, Sunna MC, Bravenec BJ, Azizad O, Farrell B, Minhajuddin A, Stewart JW, Liang LW, Moon TS, Fox PE, Ebeling CG, Smith MN, Trousdale D, Ogunnaike BO; EvK Clinical Trial Collaborators. Etomidate versus ketamine for emergency endotracheal intubation: a randomized clinical trial. Intensive Care Med. 2022 Jan;48(1):78-91. doi: 10.1007/s00134-021-06577-x. Epub 2021 Dec 14.
PMID: 34904190DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Gerald Matchett
- Organization
- UT-Southwestern Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Gerald Matchett, MD
University of Texas
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor of Medicine
Study Record Dates
First Submitted
December 11, 2015
First Posted
December 31, 2015
Study Start
June 6, 2016
Primary Completion
December 1, 2020
Study Completion
December 1, 2020
Last Updated
December 15, 2021
Results First Posted
December 15, 2021
Record last verified: 2021-11
Data Sharing
- IPD Sharing
- Will not share
Aggregate anonymous data will be published in accord with our IRB approval.